PROTECT
PROTECT is a unique opportunity to bridge the gap between academia and industry in Cyprus. The consortium consists of a diverse, yet balanced, partnership of 2 research institutions (UCY, CyI), 1 private clinical center (GOC) and 2 small enterprises (3ahealth, EUNDO). Partners have ideal expertise complementarity in engineering, computer science, mathematics, medicine and oncology, and an excellent track-record in R&D and commercial exploitation in healthcare technologies. The clinical problem and the proposed medical device solution were jointly identified by the project’s clinical and technical partners, while the project objectives and proposed methodology were defined to maximize PROTECT’s potential, focusing on the real-world clinical need
Publishable Summary: PROTECT project, takes up the challenge of boosting the accuracy and efficiency of High Dose-Rate BrachyTherapy (HDRBT) through an automatic, data-driven, cloud-based, computer platform for the realistic training of preoperative and intraoperative planning of HDRBT. We aim to establish a cutting-edge generative Artificial Intelligence (AI) framework for automatic delineation of the prostate gland and urethra during HDRBT, which will provide a substantial speed-up over manual interventions, reducing the chance of errors, optimizing the application of therapy and minimizing harmful side effects. In addition we aim to deliver a novel in silico modeling tool for personalized predictions of needle insertion that account for the induced deformation on the prostate tissue.
Duration: May 2024 – April 2026
Please visit the PROTECT project website for more updates: https://protect-prostate.eu/
The Project Automated model-based surgical planning tool for PROstaTE Cancer brachyTherapy – PROTECT, CODEVELOP-AG-SH-HE-0823-00114 is funded by the European Union Recovery and Resilience Facility of the NextGenerationEU instrument, through the Research and Innovation Foundation.
Co-funded by:
